236 related articles for article (PubMed ID: 27914267)
1. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature.
Chen Y; Zhang M; Jin H; Tang Y; Wang H; Xu Q; Li Y; Li F; Huang Y
Biomaterials; 2017 Feb; 116():57-68. PubMed ID: 27914267
[TBL] [Abstract][Full Text] [Related]
2. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
3. Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance.
Chen Y; Zhang M; Jin H; Tang Y; Wu A; Xu Q; Huang Y
Mol Pharm; 2017 May; 14(5):1429-1438. PubMed ID: 28195491
[TBL] [Abstract][Full Text] [Related]
4. Genetically-engineered protein prodrug-like nanoconjugates for tumor-targeting biomimetic delivery via a SHEATH strategy.
Chang Y; Yao S; Chen Y; Huang J; Wu A; Zhang M; Xu F; Li F; Huang Y
Nanoscale; 2019 Jan; 11(2):611-621. PubMed ID: 30556550
[TBL] [Abstract][Full Text] [Related]
5. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
6. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
[TBL] [Abstract][Full Text] [Related]
7. Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.
Fang Y; Xue J; Gao S; Lu A; Yang D; Jiang H; He Y; Shi K
Drug Deliv; 2017 Dec; 24(sup1):22-32. PubMed ID: 29069920
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
9. Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting.
Stefan N; Zimmermann M; Simon M; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2014 Dec; 25(12):2144-56. PubMed ID: 25350699
[TBL] [Abstract][Full Text] [Related]
10. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
Luo T; Loira-Pastoriza C; Patil HP; Ucakar B; Muccioli GG; Bosquillon C; Vanbever R
J Control Release; 2016 Oct; 239():62-71. PubMed ID: 27515664
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
12. Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7-Ethyl-10-Hydroxycamptothecin.
Liu X; Si J; Zhang Q; Huang Q; Gu D; Yang H; Chen X; Shen Y; Sui M
Adv Healthc Mater; 2018 Apr; 7(7):e1701140. PubMed ID: 29334179
[TBL] [Abstract][Full Text] [Related]
13. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
14. Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation.
Böttger R; Knappe D; Hoffmann R
J Control Release; 2016 May; 230():88-94. PubMed ID: 27067364
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.
Zhu L; Wang T; Perche F; Taigind A; Torchilin VP
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17047-52. PubMed ID: 24062440
[TBL] [Abstract][Full Text] [Related]
16. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
Song H; Zhang J; Wang W; Huang P; Zhang Y; Liu J; Li C; Kong D
Colloids Surf B Biointerfaces; 2015 Dec; 136():365-74. PubMed ID: 26433349
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
[TBL] [Abstract][Full Text] [Related]
19. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
20. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor.
Nkepang G; Bio M; Rajaputra P; Awuah SG; You Y
Bioconjug Chem; 2014 Dec; 25(12):2175-88. PubMed ID: 25351441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]